| James Frederick Pehoushek, MD MPH | |
|
6320-a W Union Hills Dr., Ste 100, Glendale, AZ 85308-1051 | |
| (623) 376-7600 | |
| (623) 376-0229 |
| Full Name | James Frederick Pehoushek |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 31 Years |
| Location | 6320-a W Union Hills Dr., Glendale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104810720 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| All Dermatology, Inc. | 4284527748 | 5 |
News Archive
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery, today announced that it is initiating clinical studies of its Symphony tCGM System in critical care patients.
A new observational study by a group of scientists explores the rise in the public's fear-driven interest in unproven therapies for COVID-19, particularly chloroquine and hydroxychloroquine, by tracking the internet searches relating to the purchase of drugs in news reports or publicized by public figures. They conclude: "Stay grounded in evidence and fight misinformation." The research letter and accompanying editorial comment are published in the journal JAMA Internal Medicine.
Abaloparatide-SC, an injectable drug being studied for the treatment of postmenopausal osteoporosis, reduces the rate of new spinal fractures by a statistically significant 86 percent and as well as statistically significant reductions in the fracture rate at other parts of the body, a phase 3 clinical trial finds. Results of the ACTIVE fracture prevention trial will be described in a late-breaking oral presentation Thursday at the Endocrine Society's 97th annual meeting in San Diego.
The replacement of "mixed episodes" with "mixed features" in DSM-5 in order to counter a lack of specificity overlooks two of the core features of mixed states, suggests research published in the Journal of Affective Disorders.
› Verified 9 days ago
| Entity Name | All Dermatology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023199544 PECOS PAC ID: 4284527748 Enrollment ID: O20040206000757 |
News Archive
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery, today announced that it is initiating clinical studies of its Symphony tCGM System in critical care patients.
A new observational study by a group of scientists explores the rise in the public's fear-driven interest in unproven therapies for COVID-19, particularly chloroquine and hydroxychloroquine, by tracking the internet searches relating to the purchase of drugs in news reports or publicized by public figures. They conclude: "Stay grounded in evidence and fight misinformation." The research letter and accompanying editorial comment are published in the journal JAMA Internal Medicine.
Abaloparatide-SC, an injectable drug being studied for the treatment of postmenopausal osteoporosis, reduces the rate of new spinal fractures by a statistically significant 86 percent and as well as statistically significant reductions in the fracture rate at other parts of the body, a phase 3 clinical trial finds. Results of the ACTIVE fracture prevention trial will be described in a late-breaking oral presentation Thursday at the Endocrine Society's 97th annual meeting in San Diego.
The replacement of "mixed episodes" with "mixed features" in DSM-5 in order to counter a lack of specificity overlooks two of the core features of mixed states, suggests research published in the Journal of Affective Disorders.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Frederick Pehoushek, MD MPH 14239 W Bell Rd, Suite 101, Surprise, AZ 85374-2469 Ph: (623) 544-7755 | James Frederick Pehoushek, MD MPH 6320-a W Union Hills Dr., Ste 100, Glendale, AZ 85308-1051 Ph: (623) 376-7600 |
News Archive
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery, today announced that it is initiating clinical studies of its Symphony tCGM System in critical care patients.
A new observational study by a group of scientists explores the rise in the public's fear-driven interest in unproven therapies for COVID-19, particularly chloroquine and hydroxychloroquine, by tracking the internet searches relating to the purchase of drugs in news reports or publicized by public figures. They conclude: "Stay grounded in evidence and fight misinformation." The research letter and accompanying editorial comment are published in the journal JAMA Internal Medicine.
Abaloparatide-SC, an injectable drug being studied for the treatment of postmenopausal osteoporosis, reduces the rate of new spinal fractures by a statistically significant 86 percent and as well as statistically significant reductions in the fracture rate at other parts of the body, a phase 3 clinical trial finds. Results of the ACTIVE fracture prevention trial will be described in a late-breaking oral presentation Thursday at the Endocrine Society's 97th annual meeting in San Diego.
The replacement of "mixed episodes" with "mixed features" in DSM-5 in order to counter a lack of specificity overlooks two of the core features of mixed states, suggests research published in the Journal of Affective Disorders.
› Verified 9 days ago
Erik Jason Martinez, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11851 N 51st Ave Ste E130, Glendale, AZ 85304 Phone: 623-703-4718 Fax: 623-703-4718 | |
Dr. Ryan A. Stevens, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 18699 N 67th Ave Ste 220, Glendale, AZ 85308 Phone: 480-905-8485 Fax: 480-905-7274 | |
Dr. Julio Hernandez, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6525 W Sack Dr, Ste 307, Glendale, AZ 85308 Phone: 623-825-5300 Fax: 623-825-0938 | |
Dr. Lara E. Rosenbaum, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6316 W Union Hills Dr Ste 200, Glendale, AZ 85308 Phone: 480-905-8485 Fax: 480-905-7274 |